Skip to main content

Company ESG Risk Ratings

Corcept Therapeutics, Inc.

Industry Group: Pharmaceuticals

Country/Region: United States of America

Identifier: NAS:CORT

Full time employees: 352

ESG Risk Rating

Core
28.1
Medium Risk
0-10
10-20
20-30
30-40
40+

Ranking

Industry Group (1st = lowest risk)

Pharmaceuticals 359 out of 851


Universe

Global Universe 9396 out of 15100


Last Full Update: Mar 21, 2024
Last Update: Jun 15, 2024

What are the ESG Risk Ratings?

Compare Corcept Therapeutics, Inc. with other industry peers.

Industry Comparison

Company ESG Risk Rating Industry Rank
H. Lundbeck A/S
22.3
 
 
 
 
 
Medium
119 out of 851
Corcept Therapeutics, Inc.
28.1
 
 
 
 
 
Medium
359 out of 851
SK Biopharmaceuticals Co., Ltd.
28.5
 
 
 
 
 
Medium
375 out of 851
Yuhan Corp.
32.7
 
 
 
 
 
High
557 out of 851
Haisco Pharmaceutical Group Co., Ltd.
36.1
 
 
 
 
 
High
711 out of 851

For corporate professionals interested in direct competitor insights

Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.

Our Approach to Calculating ESG Risk

The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.

Corcept Therapeutics, Inc.'s Exposure is Medium

Low
Medium
High

Management

Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.

Corcept Therapeutics, Inc.'s Management of ESG Material Risk is Average

Weak
Average
Strong

How do the ESG Risk Ratings work?

Controversy Rating

Highest Controversy level that has impacted Corcept Therapeutics, Inc.'s ESG Risk Rating in the last three years

Highest Controversy Level

blurred controversy level

Contributing Events

blurred controversy events

Highest Controversy Events Locations

world map blurred
Get in Touch Contact us to learn more about our Controversies Research Report

Learn how the ESG Risk Ratings are used by our clients

Corporates

Leverage Sustainalytics' ESG Risk Ratings to understand and promote your corporate ESG performance with internal and external stakeholders.

Banks and Lenders

Banks and lenders can use our ESG Risk Ratings and data as a part of a broader analysis of their clients as well as for innovative product solutions such as sustainability linked loans.

Investors

The ESG Risk Ratings can help investors to identify, understand and manage ESG risks at the security and portfolio level with the aim of improving the long-term performance of their equity and fixed income securities.